Scientific Officer BioAgilytix Labs, LLC Durham, North Carolina
Join Amanda Hays and several authors in Poster Forum #7 in the Solution Center for a conversation about posters on the topic, “Biomarkers in Drug Development”, that she is especially excited about.
T1130-04-27 Anticancer Effects of Proteins and miRNAs Picked out by Proteomic Analysis of NK Cell-Derived EVs in Combination with Carboplatin in Resistant Lung Cancer: Role of PDL1/PD-1, SOD2, PARP, NF-kB and SET, Aakash Nathani, MS, Florida A&M University, Best Abstract Award winner
T1430-10-65 Novel Biomarkers for Inflammatory Bowel Disease, Vineet A. Joshi, MS, University of Nebraska Medical Center, Best Abstract Award winner
W1230-06-37 PD-L1 Gene Expression Quantification in Single Cell on Tissue for Accurately Predicting Response to ICIs, Corinne Ramos, Aliri
T1130-06-39 Targeted Profiling of Lipid Mediators as Serum Biomarkers of Inflammation in a Case Study, Ashish Vaswani, Ph.D., Moderna Therapeutics
M1430-06-37 Toward Development of a New QCM-D Based Method for Rapid Detection of a Novel Biomarker of Morbidity and Mortality Risk in Sepsis Patients, Eman Kamel, MS, University of Iowa
M1330-04-26 Urinary MicroRNAs as Possible Biomarkers of Cisplatin-Induced Nephrotoxicity in Patients with Head and Neck Cancer, Eder C. Pincinato, UNICAMP